Anzeige
Mehr »
Login
Sonntag, 19.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
100-Milliarden-Dollar-Marke: Wie die strategische Vision eines Unternehmens historischem Meilenstein passt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
297 Leser
Artikel bewerten:
(1)

MacPaw Concludes Successful Internship Program in Collaboration with MIT-Ukraine

Finanznachrichten News

BOSTON, Sept. 6, 2024 /PRNewswire/ -- Less than one year after opening an office in Boston, MacPaw, a leading macOS and iOS software maker, is excited to announce the conclusion of its first student internship program in collaboration with the MIT-Ukraine program.

Main Visual

A Vision of Mutual Growth and Innovation

In response to Russia's full-scale invasion of Ukraine, MIT has launched the MIT-Ukraine program to serve as a hub for its technological and humanitarian efforts. This program engages MIT students, faculty, and staff in global efforts to preserve and rebuild Ukraine. One of the program's key components is the MIT International Science and Technology Initiatives (MISTI) internships, which enable MIT talent to work on hands-on projects supporting Ukraine.

"The MIT-Ukraine program was established to harness MIT's engineering and technology expertise to support Ukraine during these challenging times," said Svitlana Krasynska, program manager of MIT-Ukraine. "While our major focus is on internships, the program also aims to engage the MIT community through collaborative research and by keeping the campus informed about the ongoing situation in Ukraine. Our goal is to establish long-term collaborations where our students can support companies like MacPaw in their efforts to contribute to Ukraine's recovery and growth."

Hands-On Experience

This program collaboration provided two MIT students with the unique opportunity to work closely with MacPaw's technological research and development team, which specializes in transforming research ideas into practical applications.

The interns focused on identifying the most effective methods for highlighting important software updates for users, including the possibility of automating the update process. Over just 2.5 months, they conducted extensive research, chose the optimal approach, and organized data and ML models to enhance the update process. Their efforts show great improvement in how MacPaw manages software updates.

"We aimed to fully integrate the students into our workflow and culture, ensuring they felt like integral members of our team," said Sergii Krivoblotsky, Head of the Technological Research and Development Center at MacPaw."We provided them with both comprehensive support and the freedom to suggest and implement changes. This approach offered them invaluable hands-on industry experience, allowing them to gain a deep understanding of our processes from within. This philosophy aligns closely with MIT-Ukraine's approach, which also aims to engage MIT students into real-world projects."

Setting a Benchmark for Future Collaborations

Following the success of this collaboration, MacPaw is exploring opportunities to deepen its relationship with MIT. The company remains committed to fostering the next generation of technology innovators and furthering its connections with interns and the higher education ecosystem, both in Boston and globally.

MacPaw is committed to forming long-term partnerships with top universities worldwide to attract the brightest minds to the company. The Technological Research and Development team continuously seeks new talent and diverse perspectives to drive innovation, accelerate research, and deepen expertise. This strategic focus on collaboration with academic institutions ensures that MacPaw remains at the forefront of technological advancements.

About MacPaw

MacPaw develops and distributes innovative software for macOS and iOS that simplifies the lives of Mac users. Renowned for its meticulously crafted products, such as CleanMyMac X, CleanMy®Phone, Setapp, and ClearVPN, and known for its Moonlock cybersecurity division, MacPaw is dedicated to enhancing and securing the Mac user experience. Founded in Kyiv, Ukraine, with a subsidiary office in Boston, MacPaw serves over 30 million users worldwide. With one in every five Mac users having at least one MacPaw app, the company is a trusted leader in the Mac software ecosystem. MacPaw has its own Technological R&D unit that works with software technology advances in human-computer interaction and related areas, transforming research ideas into practical applications in MacPaw products.

About MIT-Ukraine

The MIT-Ukraine program is committed to mobilizing MIT's scientific and technical expertise in support of Ukraine. While the program was launched to address the mounting challenges resulting from the ongoing Russian war, it intends to partake in designing creative solutions and innovation supporting Ukraine's reconstruction and democracy-building in the long-term future. Being a leading science, technology and engineering research university, MIT is perfectly positioned to mobilize students, faculty, and staff to participate in global efforts of preserving and rebuilding Ukraine.

Media Kit

Media Contacts

MacPaw
Kateryna Andriienko
PR Specialist
kathy.andriienko@macpaw.com
pr_team@macpaw.com

Photo - https://mma.prnewswire.com/media/2497827/Main_Visual.jpg
Photo - https://mma.prnewswire.com/media/2497828/2_1.jpg

On the photo from left to right: Nata Stulova, Senior Research Scientist at MacPaw, Milin Tunsiricharoengul, Intern from MIT, Sergii Krivoblotsky, Head of TR&D at MacPaw

Cision View original content:https://www.prnewswire.co.uk/news-releases/macpaw-concludes-successful-internship-program-in-collaboration-with-mit-ukraine-302239966.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.